Bionano Genomics (BNGO) Non-Current Assets (2017 - 2026)

Bionano Genomics' Non-Current Assets history runs 10 years deep, the most recent figure standing at $25.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 22.86% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $117.6 million (down 34.59% YoY), while the FY2025 annual figure was $28.2 million, down 24.16% from the prior year.
• Non-Current Assets came in at $25.8 million for Q1 2026 at Bionano Genomics, down from $28.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $150.2 million in Q4 2022 to a low of $25.8 million in Q1 2026.
• A 5-year average of $75.7 million and a median of $72.4 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets soared 624.51% in 2022 and sank 53.77% in 2024, its largest moves.
• Bionano Genomics' Non-Current Assets stood at $150.2 million in 2022, then slumped by 50.54% to $74.3 million in 2023, then plunged by 49.95% to $37.2 million in 2024, then decreased by 24.16% to $28.2 million in 2025, then dropped by 8.4% to $25.8 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $25.8 million, $28.2 million, and $30.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison